P3 Health Partners (PIII) Return on Sales: 2021-2025
Historic Return on Sales for P3 Health Partners (PIII) over the last 6 years, with Q3 2025 value amounting to 0.2%.
- P3 Health Partners' Return on Sales rose 800.0% to 0.2% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.2%, marking a year-over-year decrease of 300.0%. This contributed to the annual value of 0.21% for FY2024, which is 600.0% down from last year.
- Latest data reveals that P3 Health Partners reported Return on Sales of 0.2% as of Q3 2025, which was up 800.0% from 0.12% recorded in Q2 2025.
- Over the past 5 years, P3 Health Partners' Return on Sales peaked at 0.08% during Q2 2024, and registered a low of 3.35% during Q2 2022.
- Its 5-year average for Return on Sales is 0.46%, with a median of 0.2% in 2025.
- In the last 5 years, P3 Health Partners' Return on Sales crashed by -31500bps in 2022 and then skyrocketed by 32700bps in 2023.
- P3 Health Partners' Return on Sales (Quarter) stood at 0.48% in 2021, then tumbled by -333bps to 2.06% in 2022, then soared by 90bps to 0.2% in 2023, then tumbled by -75bps to 0.35% in 2024, then surged by 42bps to 0.2% in 2025.
- Its Return on Sales was 0.2% in Q3 2025, compared to 0.12% in Q2 2025 and 0.12% in Q1 2025.